Vincerx Pharma, Inc. (VINC) Financials
VINC Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-09-30 | 26.3 million | 10.5 million |
2023-06-30 | 35.3 million | 11.1 million |
2023-03-31 | 47.4 million | 13.0 million |
2022-12-31 | 59.3 million | 11.6 million |
VINC Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-09-30 | -6.6 million | 1.3 million |
2023-06-30 | -12.7 million | 694000 |
2023-03-31 | -13.1 million | 1.1 million |
2022-12-31 | -13.8 million | 1.5 million |
VINC Net Income
No data available :(
VINC Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-09-30 | 20.8 million | - | 2.8 million |
2023-06-30 | 27.4 million | - | 3.0 million |
2023-03-31 | 39.8 million | - | 3.3 million |
2022-12-31 | 52.5 million | - | 3.4 million |
VINC Shares Outstanding
VINC Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-09-30 | - | 6.8 million | 3.5 million | - |
2023-06-30 | - | 7.9 million | 3.8 million | - |
2023-03-31 | - | 10.6 million | 4.5 million | - |
2022-12-31 | - | 11.4 million | 4.1 million | - |
VINC Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-09-30 | - | 254000 |
2023-06-30 | - | 249000 |
2023-03-31 | - | 154000 |
2022-12-31 | - | 241000 |
VINC
Price: $0.89
52 week price:
Earnings Per Share: -1.89 USD
P/E Ratio: -0.68
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 181372
Market Capitalization: 21.0 million